NIA Impact Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.92M Sell
49,642
-4,712
-9% -$660K 3.08% 6
2025
Q4
$6.67M Buy
54,354
+3,304
+6% +$402K 2.24% 10
2025
Q3
$5.67M Buy
51,050
+1,154
+2% +$131K 1.84% 19
2025
Q2
$5.53M Sell
49,896
-96
-0.2% -$10.2K 1.91% 17
2025
Q1
$5.6M Sell
49,992
-4,408
-8% -$455K 2.08% 16
2024
Q4
$5.02M Sell
54,400
-15,059
-22% -$1.36M 1.63% 21
2024
Q3
$5.82M Sell
69,459
-1,974
-3% -$151K 1.93% 20
2024
Q2
$4.9M Sell
71,433
-2,574
-3% -$172K 1.76% 19
2024
Q1
$5.42M Buy
+74,007
New +$5.69M 2.16% 17
2023
Q2
$6.63M Sell
82,857
-578
-0.7% -$46.1K 3.77% 7
2023
Q1
$6.92M Buy
83,435
+1,787
+2% +$148K 3.74% 4
2022
Q4
$7.01M Buy
81,648
+7,246
+10% +$574K 4.07% 3
2022
Q3
$4.59M Buy
74,402
+16,164
+28% +$1.02M 2.83% 13
2022
Q2
$3.6M Buy
58,238
+18,283
+46% +$1.13M 2.16% 18
2022
Q1
$2.38M Buy
39,955
+2,876
+8% +$184K 1.15% 35
2021
Q4
$2.29M Sell
37,079
-4,023
-10% -$277K 1.22% 32
2021
Q3
$2.87M Buy
41,102
+620
+2% +$43.6K 1.22% 34
2021
Q2
$2.79M Buy
40,482
+952
+2% +$63.6K 1.36% 34
2021
Q1
$2.56M Buy
39,530
+3,638
+10% +$235K 1.38% 32
2020
Q4
$2.24M Buy
+35,892
New +$2.17M 1.17% 37

Other funds holding GILD

NIA Impact Advisors's GILD Position: Q1 2026 in Review

NIA Impact Advisors reduced its Gilead Sciences (GILD) stake by 8.7% in Q1 2026, selling an estimated $660K and leaving 49,642 shares worth $6.92M. The position accounts for 3.08% of the portfolio, ranked #6.

NIA Impact Advisors first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. The position peaked at $7.01M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • NIA Impact Advisors held 49,642 shares of Gilead Sciences worth $6.92M as of Q1 2026.
  • NIA Impact Advisors sold 4,712 Gilead Sciences shares in Q1 2026, an estimated $660K.
  • Gilead Sciences made up 3.08% of NIA Impact Advisors's portfolio in Q1 2026, its #6 holding.
  • NIA Impact Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
  • NIA Impact Advisors's Gilead Sciences position peaked at $7.01M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on NIA Impact Advisors's 13F filing for Q1 2026, filed 8 May 2026.